US Kalytera buys Israel medical cannabis firm Talent for over $10m – The Times of Israel

Posted: February 20, 2017 at 1:45 pm


The Times of Israel
US Kalytera buys Israel medical cannabis firm Talent for over $10m
The Times of Israel
Talent is currently studying the use of cannabidiol (CBD) an antioxidant extracted from the cannabis plant to prevent and treat Graft versus Host Disease (GvHD), a life-threatening condition that can occur after stem cell or bone marrow ...
Kalytera Therapeutics Acquires Israeli Cannabis DrugmakerThe Jewish Press - JewishPress.com

all 2 news articles »

More:
US Kalytera buys Israel medical cannabis firm Talent for over $10m - The Times of Israel

Related Posts

Comments are closed.

Archives